Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7394)
All Articles published online
|
Publishing Process of This Article
|
Feb 12, 2018 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wongwarangkana C, Wanlapakorn N, Chansaenroj J, Poovorawan Y. Retinoic acid receptor beta promoter methylation and risk of cervical cancer. World J Virol 2018; 7(1): 1-9 [PMID: 29468136 DOI: 10.5501/wjv.v7.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i1/1.htm |
| Number | Citing Articles |
| 1 |
Guokun Liu, Xuan Du, Li Xiao, Qing Zeng, QianLing Liu, Xiao-Jie Lu. Activation of FGD5-AS1 Promotes Progression of Cervical Cancer through Regulating BST2 to Inhibit Macrophage M1 Polarization. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/5857214
|
| 2 |
Kheirollah Yari, Zohreh Rahimi. Promoter Methylation Status of the Retinoic Acid Receptor-Beta 2 Gene in Breast Cancer Patients: A Case Control Study and Systematic Review. Breast Care 2019; 14(2): 117 doi: 10.1159/000489874
|
| 3 |
Sarah T.K. Sin, Yan Li, Ming Liu, Stephanie Ma, Xin-Yuan Guan. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling. Gynecologic Oncology 2019; 152(1): 185 doi: 10.1016/j.ygyno.2018.10.039
|
| 4 |
Feier Wang, Lizhu Ye, Xinhang Jiang, Rui Zhang, Shen Chen, Liping Chen, Hongyao Yu, Xiaowen Zeng, Daochuan Li, Xiumei Xing, Yongmei Xiao, Wen Chen. Specific CpG sites methylation is associated with hematotoxicity in low-dose benzene-exposed workers. Environment International 2024; 186: 108645 doi: 10.1016/j.envint.2024.108645
|
| 5 |
Nisha Rani Dahiya, Boris A. Leibovitch, Rama Kadamb, Nidhi Bansal, Samuel Waxman. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells. Cells 2022; 11(7): 1179 doi: 10.3390/cells11071179
|
| 6 |
Kousalya Lavudi, Shreya Madhav Nuguri, Zianne Olverson, Anantha Krishna Dhanabalan, Srinivas Patnaik, Rekha Rani Kokkanti. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1254612
|
| 7 |
Shasha He, Yeqian Feng, Wen Zou, Jingjing Wang, Guiyuan Li, Wei Xiong, Yangchun Xie, Jin-an Ma, Xianling Liu. The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to Cisplatin. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.784525
|
| 8 |
Xiaoqiong Luo, Jingxi Wei, Feng-lian Yang, Xiao-xia Pang, Feng Shi, Yu-xia Wei, Bi-yun Liao, Jun-li Wang. RETRACTED ARTICLE: Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1042-4
|
| 9 |
Ya Niu, Shuang Tang. Circadian clock‐mediated nuclear receptors in cancer. Journal of Cellular Physiology 2022; 237(12): 4428 doi: 10.1002/jcp.30905
|
| 10 |
|